Experts in Leukemia and Blood Cancer

Working with many rare forms of blood disorders, the Stanford Hematology Program brings together a multispecialty team of experts dedicated to treating leukemia as well as other benign and malignant hematologic disorders.

Hematology Program
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-498-6000 Getting Here
Maps & Directions
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-498-6000 Getting Here

Our Doctors

Care and Treatment of Leukemia and Blood Cancers

Overview of Blood Cancers, Leukemia, and Hematological Malignancies

Blood cancers are hematological disorders that affect the cells that make up blood, bone marrow, and lymph. While many hematological cancers are relatively rare, the specialists at the Stanford Hematology Program are experienced in managing even the most complex cases. Our team of world-renowned doctors provides the most advanced diagnostic technologies and treatments available today for both benign and malignant hematologic disorders.

Our goal is to improve the survival and quality of life of patients. Stanford Cancer Center doctors have particular expertise in the management of:

Acute lymphoblastic leukemia

A cancer of the blood in which too many lymphocytes, a type of white blood cell which normally fights infection, are produced by the bone marrow and by organs of the lymph system. 

Acute myeloid leukemia (AML)

A type of blood cancer in which bone marrow makes too many granulocytes (a type of white blood cell that normally fights infection). The term "acute" means the disease progresses rapidly. 

Acute promyelocytic leukemia (APL)

A form of acute myelogenous leukemia (AML) that is caused when part of chromosome 15 and chromosome 17 are swapped in an action called a "translocation." APL accounts for about 5-10% of all cases of AML and is most likely to affect young adults.

Agnogenic myeloid metaplasia (AMM)

A type of cancer that forms in the bone marrow. It is similar to CML, but lacks the genetic defect known to cause CML.


A medical condition in which the red blood cell count is less than normal.

Aplastic anemia

A rare condition that occurs when the body stops producing enough new blood cells, causing fatigue and an increased risk of infections and uncontrolled bleeding. 

Chronic lymphocytic leukemia (CLL)

A type of blood cancer in which bone marrow and other lymphatic system organs slowly make too many lymphocytes (a type of white blood cell). The term "chronic" means the disease progresses more slowly.  

Chronic myelogenous leukemia

A chronic form of cancer that starts in the blood-forming cells of the bone marrow and invades the blood and other parts of the body over time.

Essential thrombocythemia (ET)

A type of leukemia in which bone marrow produces too many platelets, increasing the risk of blood clots which can lead to strokes and heart attacks.

Hairy cell leukemia

A cancer of the bone marrow and blood in which lymphocytes become abnormal.


An inherited bleeding, or coagulation, disorder.

Immune (idiopathic) thrombocytopenia purpura

ITP is a blood disorder characterized by an abnormal decrease in the number of platelets in the blood. 


Cancer of the blood that develops in the bone marrow, which produces the three major blood cells: white blood cells, red blood cells, and platelets.

Myelodysplastic syndrome

A group of diseases that cause immature blood cells to accumulate in the bone marrow leading to a shortage of mature blood cells.

Myeloproliferative disorders

A group of diseases of the bone marrow in which too many red blood cells, platelets, or white blood cells are made. It can progress into AML.

Multiple myeloma

A type of cancer that affects certain white blood cells and collects in the bone marrow and the outer layer of the bone.

Prolymphocytic leukemia

A rare, aggressive type of cancer involving malignant B-cells or T-cells in the blood, bone marrow, and tissues. It is often classified as a type of CLL.


Venous thrombosis is when the blood clot obstructs a vein, and arterial thrombosis is when the blood clot obstructs an artery.

Childhood leukemia

Leukemia is the most common form of cancer in childhood. It affects approximately 3,000 children each year in the United States, accounting for about 30% of childhood cancers. Information about childhood leukemia can be found at the Lucile Packard Children's Hospital, which is within easy walking distance from both the Stanford Cancer Center and Stanford Hospital & Clinics.

Clinical Trials

Leading research

Through their laboratory investigation and clinical research, Stanford Hematology Program clinicians are identifying the biologic mechanisms responsible for the development of hematological disorders and developing more effective therapies to address these diseases. Additionally, our doctors are engaged a number of clinical trials through the Southwest Oncology Group and the Eastern Cooperative Oncology Group, as well as in Stanford-based studies.

Innovative research in clinical trials

Stanford has an extensive portfolio of clinical trials using novel therapies and investigational agents for all types of leukemia, multiple myeloma, and myelopfoliferative neoplasms.

Clinical trial participation

Doctors from the Division of Hematology are engaged a number of clinical trials through the Southwest Oncology Group and the Eastern Cooperative Oncology Group, as well as in Stanford-based studies. Some of our current clinical trials include:

  • Antibody therapy for chronic lymphocytic leukemia
  • Arsenic trioxide for promyelocytic leukemia
  • Anti-angiogenesis therapies (treatments that seek to prevent tumors from generating new blood supplies to nourish themselves)

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all hematology eligibility flowcharts at the Stanford Cancer Institute.

For Patients


Review the New Patient Packet for information about:

  • What to expect on the day of your appointment
  • Maps, directions, parking, public transit options, and contact information
  • Other patient resources

Bring completed forms found in the Hematology New Patient Letter.


Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care (formerly Stanford Hospital & Clinics). 

International Patients
Phone: +1 650-723-8561

Call us to make an appointment



For Health Care Professionals


Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.

Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.


Fax a referral form with supporting documentation to 650-320-9443.

Please note, though this form is from Stanford Health Care (formerly Stanford Hospital & Clinics), it is also used for all Cancer Center referrals.

Track your patients' progress and communicate with Stanford providers securely online.

Learn More About PRISM »